|
Market Closed -
TEL AVIV STOCK EXCHANGE
12:24:57 28/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1,122.00 ILa | -2.01% |
|
-0.71% | +2.56% |
| Market Cap | 128M 0 41.63M 36.61M 34.62M 31.4M 58.97M 4B 59.32M 415M 160M 2.04B 156M 153M 6.55B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 256M 0 83.24M 73.21M 69.23M 62.79M 118M 7.99B 119M 829M 320M 4.08B 313M 306M 13.1B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.01% | ||
| 1 week | -0.71% | ||
| Current month | +5.95% | ||
| 1 month | +7.37% | ||
| 3 months | +5.25% | ||
| 6 months | -3.69% | ||
| Current year | +2.56% |
| 1 week | 1,099 |  | 1,237 |
| 1 month | 1,032 | | 1,237 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,779 |
| 5 years | 1,006 | | 2,610 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 23/08/1993 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 31/10/2018 |
| President | 80 | 27/06/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 24/06/2010 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 14/04/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.01% | -0.71% | +1.54% | -36.61% | 42.87M | |
| -1.19% | -2.10% | +12.59% | +92.69% | 101B | |
| +0.03% | -2.26% | +43.32% | +150.22% | 50.99B | |
| -0.39% | +0.39% | -14.67% | +290.84% | 20.76B | |
| -0.81% | -0.06% | -11.43% | -12.26% | 7.93B | |
| +3.68% | +3.52% | -35.25% | -36.39% | 6.81B | |
| -0.44% | +5.87% | +1.30% | +19.97% | 6.79B | |
| +0.13% | -0.80% | -18.04% | -33.18% | 5.92B | |
| +0.06% | +1.23% | -2.65% | +23.10% | 4.96B | |
| -2.94% | +5.56% | +16.41% | +19.61% | 4.11B | |
| Average | -0.30% | +1.40% | -0.69% | +47.80% | 20.94B | |
| Weighted average by Cap. | -0.56% | -0.56% | +13.38% | +109.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 105M 91.97M 86.97M 78.88M 148M 10.04B 149M 1.04B 402M 5.12B 393M 384M 16.46B | 301M 0 97.83M 86.05M 81.37M 73.8M 139M 9.39B 139M 974M 376M 4.79B 367M 359M 15.4B |
| Net income | 6.21M 0 2.02M 1.77M 1.68M 1.52M 2.86M 194M 2.87M 20.09M 7.76M 98.81M 7.57M 7.41M 318M | -18.07M -0 -5.87M -5.17M -4.89M -4.43M -8.32M -564M -8.37M -58.5M -22.59M -288M -22.06M -21.58M -925M |
| Net Debt | 127M 0 41.31M 36.33M 34.36M 31.16M 58.52M 3.97B 58.86M 411M 159M 2.02B 155M 152M 6.5B | 128M 0 41.61M 36.6M 34.61M 31.39M 58.95M 3.99B 59.29M 414M 160M 2.04B 156M 153M 6.55B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/09/26 | ILA 1,122.00 | -2.01% | 1,675 |
| 24/09/26 | ILA 1,145.00 | -2.72% | 1,750 |
| 23/09/26 | ILA 1,177.00 | +3.06% | 11,089 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
